Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 0.9200
+0.0760 (9.00%)
Mar 25, 2026, 5:20 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 25.66 million as of March 25, 2026. Its market cap has decreased by -67.56% in one year.
Market Cap
25.66M
Enterprise Value
17.74M
Revenue
36.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.92
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 25.66M, a decrease of -89.57%. That is a compound annual growth rate of -42.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 25.66M | -26.61% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.54B |
| Dicot Pharma AB | 844.93M |
| Cinclus Pharma Holding AB | 833.03M |
| Orexo AB | 788.60M |
| Nanexa AB | 625.42M |
| Enzymatica AB | 555.86M |
| Moberg Pharma AB | 493.51M |
| Klaria Pharma Holding AB (publ.) | 187.93M |